Clinical use of pentoxifylline for activation of immotile testicular sperm before ICSI in patients with azoospermia.

The testicular sperm from biopsy and frozen/thawed tissue are frequently immotile. The purpose of our retrospective study was to assess the effect of short exposure of testicular samples with only immotile sperm to pentoxifylline (PF)-sperm motility stimulator. In 77 of 294 (26.2%) testicular sperm ablation/testicular sperm extraction-intracytoplasmic sperm injection (TESA/TESE-ICSI) cycles in patients with azoospermia, only immotile sperm were found in biopsies even after 2 hours of incubation of tissue in the medium. These 77 cycles were divided into 2 groups. In group 1 (cycles between 1999 and 2001; n = 30), ICSI was performed with untreated immotile sperm. In group 2 (cycles between 2002 and 2004; n = 47), immotile testicular sperm were treated for 20 minutes with pentoxifylline (PF) (1.76 mM) before ICSI. Both groups had the same proportion of ICSI cycles with fresh, frozen/thawed, and aspirated testicular sperm. The overall pregnancy rate of TESA/TESE-ICSI did not vary during the study period. In 45 of 47 (95.7%) testicular samples with total immotility, the sperm started to move 20 minutes after PF treatment. The mean time required for ICSI was shortened in the PF group (30 minutes [minimum 10, maximum 90] vs 120 minutes [minimum 60, maximum 240]) due to easier identification of motile sperm. In comparison with the nontreated group, the PF group had a higher fertilization rate (66% vs 50.9%; P < .005) and mean number of embryos per cycle (4.7 +/- 3.3 vs 2.7 +/- 2.1; P < .01). The clinical pregnancy rate per cycle in PF and non-PF groups was 38.3% and 26.7%, respectively. By using PF in cases of only immotile testicular sperm we can cause movement of testicular sperm, allow easier identification of vital sperm, shorten the procedure, improve fertilization rates, and increase the number of embryos.

[1]  I. Taşdemir,et al.  Effect of pentoxifylline on immotile testicular spermatozoa , 2007, Journal of Assisted Reproduction and Genetics.

[2]  F. Pasqualotto,et al.  Etiology-specific outcomes of intracytoplasmic sperm injection in azoospermic patients. , 2005, Fertility and sterility.

[3]  S. Kaali,et al.  Intracytoplasmic sperm injection with motile and immotile frozen‐thawed testicular spermatozoa (the Hungarian experience) , 2005, Andrologia.

[4]  M. Blayney,et al.  Successful use of pentoxifylline in male-factor infertility and previous failure of in vitro fertilization: A prospective randomized study , 1995, Journal of Assisted Reproduction and Genetics.

[5]  C. Giorgetti,et al.  Pentoxifylline Initiates Motility in Spontaneously Immotile Epididymal and Testicular Spermatozoa and Allows Normal Fertilization, Pregnancy, and Birth After Intracytoplasmic Sperm Injection , 2000, Journal of Assisted Reproduction and Genetics.

[6]  M. Koong,et al.  Influence of motility on the outcome of in vitro fertilization/intracytoplasmic sperm injection with fresh vs. frozen testicular sperm from men with obstructive azoospermia. , 2003, Fertility and sterility.

[7]  A. Traub,et al.  Effects of 24-hour incubation after freeze-thawing on DNA fragmentation of testicular sperm from infertile and fertile men. , 2003, Fertility and sterility.

[8]  S. Wood,et al.  Effect on clinical outcome of the interval between collection of epididymal and testicular spermatozoa and intracytoplasmic sperm injection in obstructive azoospermia. , 2003, Journal of andrology.

[9]  Z. Rosenwaks,et al.  Application of intracytoplasmic sperm injection in assisted reproductive technologies. , 2003, Reproductive biomedicine online.

[10]  S. Emiliani,et al.  Increased sperm motility after in-vitro culture of testicular biopsies from obstructive azoospermic patients results in better post-thaw recovery rate. , 2000, Human reproduction.

[11]  J. Conaghan,et al.  The relative viability of human spermatozoa from the vas deferens, epididymis and testis before and after cryopreservation. , 1999, Human reproduction.

[12]  A. Acosta,et al.  Birth of twin males with normal karyotype after intracytoplasmic sperm injection with use of testicular spermatozoa from a nonmosaic patient with Klinefelter's syndrome. , 1999, Fertility and sterility.

[13]  N. Noyes,et al.  Enhancement or initiation of testicular sperm motility by in vitro culture of testicular tissue. , 1999, Fertility and sterility.

[14]  H. Tournaye,et al.  Results of intracytoplasmic sperm injection with ejaculated, fresh and frozen-thawed epididymal and testicular spermatozoa. , 1998, Human reproduction.

[15]  Z. Nagy,et al.  Correlation between motility of testicular spermatozoa, testicular histology and the outcome of intracytoplasmic sperm injection. , 1998, Human reproduction.

[16]  E. Katz,et al.  High fertilization rate obtained after intracytoplasmic sperm injection with 100% nonmotile spermatozoa selected by using a simple modified hypo-osmotic swelling test. , 1997, Fertility and sterility.

[17]  Z. Nagy,et al.  Comparison of different hypo-osmotic swelling solutions to select viable immotile spermatozoa for potential use in intracytoplasmic sperm injection. , 1997, Human reproduction update.

[18]  E. Fabbri,et al.  Effectiveness of pentoxifylline in semen preparation for intrauterine insemination. , 1996, Human reproduction.

[19]  K. Jarvi,et al.  The hypo-osmotic swelling test for selection of viable sperm for intracytoplasmic sperm injection in men with complete asthenozoospermia. , 1996, Fertility and sterility.

[20]  W. Künzel,et al.  Andrological work-up of patients undergoing microsurgical epididymal sperm aspiration or testicular sperm extraction. , 1996, Andrologia.

[21]  H. Tournaye,et al.  Use of pentoxifylline in assisted reproductive technology. , 1995, Human reproduction.

[22]  L. Scott,et al.  Human sperm motility-enhancing agents have detrimental effects on mouse oocytes and embryos. , 1995, Fertility and sterility.

[23]  E. Kolibianakis,et al.  Effect of pentoxifylline on human sperm motility and fertilizing capacity. , 1995, Archives of andrology.

[24]  H. Tournaye,et al.  Mouse in vitro fertilization using sperm treated with pentoxifylline and 2-deoxyadenosine. , 1994, Fertility and sterility.

[25]  H. Tournaye,et al.  The influence of pentoxifylline on motility and viability of spermatozoa from normozoospermic semen samples. , 1994, International journal of andrology.

[26]  J. Yovich.  Pentoxifylline: actions and applications in assisted reproduction. , 1993, Human reproduction.

[27]  K. Lindsay,et al.  Variability of human sperm response to immediate and prolonged exposure to pentoxifylline. , 1993, Human reproduction.

[28]  H. Tournaye,et al.  Effects of pentoxifylline on in-vitro development of preimplantation mouse embryos. , 1993, Human reproduction.

[29]  V. Kay,et al.  Pentoxifylline stimulates hyperactivation in human spermatozoa. , 1993, Human reproduction.

[30]  S. Downs,et al.  Hypoxanthine-maintained two-cell block in mouse embryos: dependence on glucose and effect of hypoxanthine phosphoribosyltransferase inhibitors. , 1991, Biology of reproduction.

[31]  J. Yovich,et al.  Influence of pentoxifylline in severe male factor infertility. , 1990, Fertility and sterility.

[32]  J. Yovich,et al.  Preliminary results using pentoxifylline in a pronuclear stage tubal transfer (PROST) program for severe male factor infertility. , 1988, Fertility and sterility.

[33]  D. Loutradis,et al.  Hypoxanthine causes a 2-cell block in random-bred mouse embryos. , 1987, Biology of reproduction.

[34]  J. Eppig,et al.  Maintenance of murine oocyte meiotic arrest: uptake and metabolism of hypoxanthine and adenosine by cumulus cell-enclosed and denuded oocytes. , 1986, Developmental biology.

[35]  A. Means,et al.  Cyclic adenosine 3',5' monophosphate, calcium and protein phosphorylation in flagellar motility. , 1983, Biology of reproduction.

[36]  L. Schwarzstein,et al.  Effect of the Phosphodiesterase Inhibitor Pentoxyfylline on Human Sperm Motility , 2009, Andrologia.

[37]  J. Brandes,et al.  Factors affecting sperm motility. IV. Incubation of human semen with caffeine, kallikrein, and other metabolically active compounds. , 1980, Fertility and sterility.